CONMED Linvatec customers are getting reminded that routine preventive maintenance may help to ensure optimum operating overall performance over the life span of the handpiece. Customers are encouraged to get in touch with CONMED Linvatec with any questions or issues at 1-800-535-8536 or email at. Customers are also reminded that any adverse encounters by using these products, and/or quality problems should also be reported to the FDA’s MedWatch Plan by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at CONMED currently estimates the pre-tax cost of completing the recall can approximate $6.0 million, which will be expensed in the business’s financial statements for the quarter ending September 30, 2009.However, since the modification in the WOMAC physical-function score is a standard outcome in assessing interventions for knee osteoarthritis and is more easily interpreted compared to the raw score at 6 months modified for the baseline rating, we revised the primary outcome before analyzing the trial data. We specified six months as the time for evaluation of the primary outcome because the scientific response to treatment is apparent by this time around. We added a 12-month assessment to determine whether the response was stable. Secondary outcomes were the pain score about the Knee Damage and Osteoarthritis Outcome Scale , which has been utilized frequently in research involving patients with a meniscal tear,15,16 and the score on the physical-activity scale of the Medical Outcomes Study 36-Item Short-Form Health Survey .